The involvement of interleukin-1 and interleukin-4 in the response of human annulus fibrosus cells to cyclic tensile strain: an altered mechanotransduction pathway with degeneration
Mechanotransduction
Strain (injury)
Interleukin 1β
Degeneration (medical)
Intervertebral Disc
Annulus (botany)
Tensile strain
DOI:
10.1186/ar3229
Publication Date:
2011-02-08T14:51:14Z
AUTHORS (4)
ABSTRACT
Recent evidence suggests that intervertebral disc (IVD) cells derived from degenerative tissue are unable to respond physiologically relevant mechanical stimuli in the 'normal' anabolic manner, but instead by increasing matrix catabolism. Understanding nature of biological processes which allow sense and (a process termed 'mechanotransduction') is important ascertain whether these signalling pathways differ with disease. The aim here was investigate involvement interleukin (IL)-1 IL-4 response annulus fibrosus (AF) nondegenerative cyclic tensile strain determine cytokine differed IVD degeneration.AF were isolated human IVDs, expanded monolayers cyclically strained presence or absence inhibitors IL-1 receptor antagonist (IL-1Ra) antibody (IL-4RAb) 10% at 1.0 Hz for 20 minutes using a Flexcell device. Total RNA extracted time points baseline control 1 24 hours poststimulation. Quantitative real-time polymerase chain reaction used analyse gene expression proteins (aggrecan type I collagen) enzymes (matrix metalloproteinase 3 (MMP3) disintegrin thrombospondin motif 4 (ADAMTS4)).Expression catabolic genes (MMP3 ADAMTS4) decreased AF 1.0-Hz stimulation, this decrease inhibited increased following pretreatment IL-1Ra IL-4RAb respectively. Treatment an identical stimulus (1.0-Hz) resulted reduced collagen), having no effect.Both involved strain. Interestingly, altered observed appears be independent either cytokine, suggesting alternative mechanotransduction pathway operation.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (69)
CITATIONS (31)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....